Diversified Consumer Services
Company Overview of University of Cardiff
University of Cardiff is an educational institution and offers degree courses for students. The company was founded in 1883 and is based in Cardiff, United Kingdom.
Cardiff, CF10 3XQ
Founded in 1883
Key Executives for University of Cardiff
Chairman of Healthcare Improvement
Director of the Wales Governance Centre
Compensation as of Fiscal Year 2014.
University of Cardiff Key Developments
University of South Wales Opens London Centre
Apr 29 14
University of South Wales announced it will open a new London Centre this autumn. Based in the heart of London's Docklands financial district, the Centre will deliver a range of postgraduate and professional courses as well as some at undergraduate level. Courses run from the Centre will include those in the areas of law and financial services and information security. These will include short CPD courses such as one-day courses in computer forensics and network security and defence. Masters-level courses in property law, accounting and Islamic banking will also form part of the new portfolio. The London Centre is located at Docklands Academy and will provide students with first-class facilities and an inspirational environment to learn and grow professionally. Students will have access to a range of learning resources, including a fully equipped library, computer labs and an extensive range of online support materials.
Marcela Votruba Joins as New Head of Cardiff University's School of Optometry and Vision Sciences
Jan 15 14
A consultant ophthalmologist and expert in inherited eye disease has been appointed the new head of Cardiff University's School of Optometry and Vision Sciences. As head of school, Professor Marcela Votruba will oversee the school's research and teaching activities.
Cancer Research Technology, The Institute of Cancer Research, Merck Serono and Cardiff University Sign Licensing Deal on Molecules That Block the WNT Signalling Pathway
Aug 2 13
Cancer Research Technology (CRT), The Institute of Cancer Research, and Merck Serono have signed a licensing deal extending a successful initial alliance to discover and develop anticancer drugs that block the WNT signalling pathway. The deal grants Merck Serono the rights to develop molecules discovered through a recently-completed four-year research collaboration between Merck Serono, CRT, The Institute of Cancer Research (ICR) and Cardiff University. At the same time the ICR, CRT and Merck Serono are signing a new two-year major collaboration to progress the existing compounds towards candidates for clinical trials and design further molecules to target the WNT signalling pathway. The work will also involve identifying biomarkers for target inhibition and patient selection. The new drug discovery work will be carried out by scientists at the ICR in London and at Merck Serono's headquarters in Darmstadt with some financial support from Cancer Research UK.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries